A, S., R, H., & J, M. (2026). Regulatory challenges of personalized medicine in the real world: Are the right patients being treated with CD19-targeting CAR T-cells? EMBO molecular medicine, 18(6), 2007. https://doi.org/10.1038/s44321-026-00436-2
Chicago Style (17th ed.) CitationA, Sebe, Hernani R, and Müller-Berghaus J. "Regulatory Challenges of Personalized Medicine in the Real World: Are the Right Patients Being Treated with CD19-targeting CAR T-cells?" EMBO Molecular Medicine 18, no. 6 (2026): 2007. https://doi.org/10.1038/s44321-026-00436-2.
MLA (9th ed.) CitationA, Sebe, et al. "Regulatory Challenges of Personalized Medicine in the Real World: Are the Right Patients Being Treated with CD19-targeting CAR T-cells?" EMBO Molecular Medicine, vol. 18, no. 6, 2026, p. 2007, https://doi.org/10.1038/s44321-026-00436-2.